Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:20 AM
Study NCT ID:
NCT00233909
Status:
COMPLETED
Last Update Posted:
2008-04-01
First Post:
2005-10-04
Brief Title:
A Trial of Gemtuzumab Ozogamicin GO in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid Leukemia
Sponsor:
Kanisa Pharmaceuticals
Organization:
Kanisa Pharmaceuticals
Organization Data
Organization:
Kanisa Pharmaceuticals
Class:
INDUSTRY
Study ID:
KAN-979-02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Kanisa Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None